Document is current
Any future updates will be listed below
-
Authors
Koblinsky, N. D.
Anderson, N. D. https://orcid.org/0000-0002-5979-2220
Ajwani, F.
Parrott, M. D.
Dawson, D.
Marzolini, S.
Oh, P.
MacIntosh, B.
Middleton, L.
Ferland, G.
Greenwood, C. E.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 18 June 2021
Accepted: 11 January 2022
First Online: 9 February 2022
Declarations
:
: The study was approved by Clinical Trials Ontario (application# 1336, last approval 21 July 2020). The lead REB site is Baycrest Health Science in Toronto (application #16–34, last approval 21 July 2020) and the COMPASS-ND portion of the study was approved by Clinical Trials Ontario (application #750, last approved June 23, 2020)<b>.</b>
: All authors gave their consent for publication.
: The authors declare no competing interests.
